Page last updated: 2024-08-23

norgestimate and Body Weight

norgestimate has been researched along with Body Weight in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's5 (55.56)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ1
Taneepanichskul, S; Tantbirojn, P1
Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD1
Burkman, RT; Fisher, AC; LaGuardia, KD1
Barnowski, C; Hampton, RM; Wan, GJ; Zhang, HF1
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM1
Anderson, FD1
Dain, MP; Janaud, A; Rouffy, J; Upmalis, D1
Kafrissen, ME1

Reviews

1 review(s) available for norgestimate and Body Weight

ArticleYear
Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Acne Vulgaris; Animals; Body Weight; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Meta-Analysis as Topic; Norgestrel; Prolactin; Receptors, Androgen; Receptors, Progesterone; Sex Hormone-Binding Globulin

1992

Trials

6 trial(s) available for norgestimate and Body Weight

ArticleYear
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
    Contraception, 2009, Volume: 79, Issue:6

    Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult

2009
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
    Contraception, 2002, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage

2002
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain

2007
Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Contraception, 2008, Volume: 77, Issue:6

    Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norgestrel; Retrospective Studies; Treatment Outcome

2008
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone

1995
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel

1992

Other Studies

2 other study(ies) available for norgestimate and Body Weight

ArticleYear
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
    Fertility and sterility, 2004, Volume: 82 Suppl 3

    Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva

2004
A norgestimate-containing oral contraceptive: review of clinical studies.
    American journal of obstetrics and gynecology, 1992, Volume: 167, Issue:4 Pt 2

    Topics: Blood Coagulation; Body Weight; Carbohydrate Metabolism; Contraceptives, Oral; Endocrine Glands; Female; Humans; Lipids; Lipoproteins; Menstrual Cycle; Norgestrel

1992